EUVIMEDEUVIMED entdecken
Open Access

Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis

Ram Vinod Roy, Nicolas Means, Geeta Rao, Sima Asfa, Venkateshwar Madka, Anindya Dey, Yushan Zhang, Monalisa Choudhury, Kar-Ming Fung, Danny N Dhanasekaran, Jacob E Friedman, Howard C Crawford und 3 weitere

Cancer Letters · 2023-12 · 578 · 216455

DOI: 10.1016/j.canlet.2023.216455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023-12. Verfasst von Ram Vinod Roy und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Pathology, The U…. Hauptthemen laut MEDLINE: Adenocarcinoma, Pancreatic Neoplasms, Pancreatitis, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaPancreatic NeoplasmsPancreatitisAdaptor Proteins, Signal TransducingAnimalsMiceAcute DiseaseCeruletideGlucoseInflammationNF-kappa BPancreas

Stichwörter der Autor:innen

Glucose intolerancePancreatic ductal adenocarcinomaPancreatitisUBAP2

Substanzen

CeruletideGlucoseNF-kappa BUbap2 protein, mouseAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Center for Cancer Prevention and Drug Development, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK, USA.
  • Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • NIGMS

Zitieren

APA

Roy, R. V., Means, N., Rao, G., Asfa, S., Madka, V., Dey, A., Zhang, Y., Choudhury, M., Fung, K. M., Dhanasekaran, D. N., Friedman, J. E., Crawford, H. C., Rao, C. V., Bhattacharya, R., & Mukherjee, P. (2023). Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis. Cancer Letters, 578, 216455. https://doi.org/10.1016/j.canlet.2023.216455

Vancouver

Roy RV, Means N, Rao G, Asfa S, Madka V, Dey A, et al. Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis. Cancer Letters. 2023;578:216455. doi:10.1016/j.canlet.2023.216455

BibTeX
@article{Roy2023,
  author = {Roy, Ram Vinod and Means, Nicolas and Rao, Geeta and Asfa, Sima and Madka, Venkateshwar and Dey, Anindya and Zhang, Yushan and Choudhury, Monalisa and Fung, Kar-Ming and Dhanasekaran, Danny N and Friedman, Jacob E and Crawford, Howard C and Rao, Chinthalapally V and Bhattacharya, Resham and Mukherjee, Priyabrata},
  title = {Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis},
  journal = {Cancer Letters},
  year = {2023},
  volume = {578},
  pages = {216455},
  doi = {10.1016/j.canlet.2023.216455}
}
Kostenlos starten →